[1]
|
Azziz, R. (2016) Introduction: Determinants of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 4-5.
https://doi.org/10.1016/j.fertnstert.2016.05.009
|
[2]
|
Diamanti-Kandarakis, E. and Dunaif, A. (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews, 33, 981-1030. https://doi.org/10.1210/er.2011-1034
|
[3]
|
Alves, M., Almeida, M., Oliani, A.H., Breitenfeld, L. and Ramalhinho, A.C. (2020) Women with Polycystic Ovary Syndrome and Other Causes of Infertility Have a Higher Prevalence of GSTT1 Deletion. Reproductive BioMedicine Online, 41, 892-901. https://doi.org/10.1016/j.rbmo.2020.06.010
|
[4]
|
Heidarzadehpilehrood, R., Pirhoushiaran, M., Abdollahzadeh, R., Binti Osman, M., Sakinah, M., Nordin, N., et al. (2022) A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility. Genes, 13, Article No. 302.
https://doi.org/10.3390/genes13020302
|
[5]
|
Echiburú, B., Pérez-Bravo, F., Maliqueo, M., Sánchez, F., Crisosto, N. and Sir-Petermannm T. (2008) Polymorphism T --> C (-34 Base Pairs) of Gene CYP17 Promoter in Women with Polycystic Ovary Syndrome Is Associated with Increased Body Weight and Insulin Resistance: A Preliminary Study. Metabolism, 57, 1765-1771.
https://doi.org/10.1016/j.metabol.2008.08.002
|
[6]
|
Zhang, X.L., Zhang, C.W., Xu, P., Liang, F.J., Che, Y.N., Xia, Y.J., et al. (2012) SNP rs2470152 in CYP19 Is Correlated to Aromatase Activity in Chinese Polycystic Ovary Syndrome Patients. Molecular Medicine Reports, 5, 245-249.
https://doi.org/10.3892/mmr.2011.616
|
[7]
|
Karagül, M., Aktaş, S., Coşkun, Y.B., Yılmaz, M. and Orekici Temel, G. (2018) GDF9 and BMP15 Expressions and Fine Structure Changes during Folliculogenesis in Polycystic Ovary Syndrome. Balkan Medical Journal, 35, 43-54.
https://doi.org/10.4274/balkanmedj.2016.1110
|
[8]
|
Yu, L., Wang, L., Tao, W., Zhang, W., Yang, S., Wang, J., et al. (2021) LHCGR and ALMS1 Defects Likely Cooperate in the Development of Polycystic Ovary Syndrome Indicated by Double-Mutant Mice. Journal of Genetics and Genomics 48, 384-395. https://doi.org/10.1016/j.jgg.2021.03.014
|
[9]
|
Zhang, B., Zhou, W., Shi, Y., Zhang, J., Cui, L. and Chen, Z.J. (2020) Lifestyle and Environmental Contributions to Ovulatory Dysfunction in Women of Polycystic Ovary Syn-drome. BMC Endocrine Disorders, 20, Article No. 19.
https://doi.org/10.1186/s12902-020-0497-6
|
[10]
|
Brutocao, C., Zaiem, F., Alsawas, M., Morrow, A.S., Murad, M.H. and Javed, A. (2018) Psychiatric Disorders in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Endocrine, 62, 318-325.
https://doi.org/10.1007/s12020-018-1692-3
|
[11]
|
Huang, X., Wang, Q., Liu, T., Pei, T., Liu, D., Zhu, H., et al. (2019) Body Fat Indices as Effective Predictors of Insulin Resistance in Obese/Non-Obese Polycystic Ovary Syndrome Women in the Southwest of China. Endocrine, 65, 81-85.
https://doi.org/10.1007/s12020-019-01912-1
|
[12]
|
Abraham, G.S., Divakar, P.Y. and Valsala, G.A. (2021) Association of Metabolic and Inflammatory Markers with Polycystic Ovarian Syndrome (PCOS): An Update. Archives of Gynecology and Obstetrics, 303, 631-643.
https://doi.org/10.1007/s00404-020-05951-2
|
[13]
|
Liu, Y., Liu, H., Li, Z., Fan, H., Yan, X., Liu, X., et al. (2021) The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment. Frontiers in Immunology, 12, Article ID: 685724. https://doi.org/10.3389/fimmu.2021.685724
|
[14]
|
Tremellen, K. and Pearce, K. (2012) Dysbiosis of Gut Microbiota (DOGMA)—A Novel Theory for the Development of Polycystic Ovarian Syndrome. Medical Hypotheses, 79, 104-112. https://doi.org/10.1016/j.mehy.2012.04.016
|
[15]
|
Guo, J., Shao, J., Yang, Y., Niu, X., Liao, J., Zhao, Q., et al. (2022) Gut Microbiota in Patients with Polycystic Ovary Syndrome: A Systematic Review. Reproductive Sciences, 29, 69-83. https://doi.org/10.1007/s43032-020-00430-0
|
[16]
|
He, F. and Li, Y. (2021) The Gut Microbial Composition in Polycystic Ovary Syndrome with Insulin Resistance: Findings from a Normal-Weight Population. Journal of Ovarian Research, 14, Article No. 50.
https://doi.org/10.1186/s13048-021-00799-9
|
[17]
|
邹燕, 程力, 罗来卫. 何成瑶教授中西医结合治疗肾虚痰瘀型多囊卵巢综合征经验[J]. 中西医结合研究, 2022, 14(1): 67-69.
|
[18]
|
李怡, 王轶蓉. 从肝论治多囊卵巢综合征[J]. 长春中医药大学学报, 2016, 32(5): 956-958.
|
[19]
|
张潆蓥, 吴涢婷, 郭午榕, 陈锦红. 脾虚痰湿型PCOS合并不孕症的中医临床及实验研究概况[J]. 云南中医中药杂志, 2020, 41(10): 70-74.
|
[20]
|
孙文华, 于馨博, 滕秀香. 达英-35联合克罗米芬治疗多囊卵巢综合征不孕症的疗效性Meta分析[J]. 中国生育健康杂志, 2022, 33(1): 84-89.
|
[21]
|
周瑛琦. 二甲双胍联合来曲唑治疗多囊卵巢综合征不孕症的临床效果评价[J]. 中国现代药物应用, 2022, 16(1): 204-206.
|
[22]
|
马志宾. 辅助生殖技术治疗多囊卵巢综合征不孕患者的临床疗效[J]. 医药论坛杂志, 2019, 40(4): 101-103.
|
[23]
|
张伟, 韩晶. 补肾活血方对肾虚血瘀型多囊卵巢综合征导致排卵障碍性不孕症患者卵巢功能及生殖内分泌指标的影响[J]. 黑龙江医药, 2021, 34(2): 368-370.
|
[24]
|
原博超, 马堃, 张辰晖, 袁苑. 补肾活血中药治疗多囊卵巢综合征导致不孕症的Meta分析[J]. 中国中药杂志, 2019, 44(6): 1080-1086.
|
[25]
|
周夏芝, 刘英莲, 岳雯, 王清, 王韫琪. 补肾活血促卵方对肾虚血瘀型多囊卵巢综合征所致不孕症的临床疗效[J]. 中国临床药理学杂志, 2017, 33(9): 786-789.
|
[26]
|
郑五二, 沈石连, 温兰香, 黄亮. 左归疏肝汤加减治疗多囊卵巢综合征不孕症的效果分析[J]. 中医临床研究, 2021, 13(5): 105-107.
|
[27]
|
聂林, 张波英, 王庆, 蔡珊. 中医健脾祛痰、活血化瘀法联合西药对肥胖型PCOS不孕症的疗效分析[J]. 中国现代医生, 2018, 56(13): 54-57.
|
[28]
|
赵红艳, 姚奏英, 季红薇, 廖燕. 自拟健脾益肾方辅助治疗多囊卵巢综合症的临床观察[J]. 中国中医药科技, 2019, 26(5): 727-728.
|
[29]
|
刘永娟, 王丽娜. 紫仙助孕汤结合调任通督针刺疗法治疗多囊卵巢综合征不孕症临床疗效及安全性观察[J]. 中华中医药学刊, 2021, 39(7): 208-211.
|
[30]
|
苏君. 温肾健脾法联合克罗米芬对脾肾阳虚证多囊卵巢综合征不孕症的临床研究[D]: [硕士学位论文]. 南宁: 广西中医药大学, 2021.
|
[31]
|
冯琳琳, 凌娜. 加减右归丸对多囊卵巢综合征不孕症患者卵泡发育及子宫内膜容受性的影响[J]. 辽宁中医药大学学报, 2022, 24(3): 168-171.
|
[32]
|
叶咏菊, 黄素英. 蔡氏多囊方联合来曲唑治疗肾虚痰瘀型多囊卵巢综合征不孕症疗效观察[J]. 浙江中医杂志, 2022, 57(2): 104-105.
|
[33]
|
王蕊蕊. 自拟补肾调经方治疗肾虚痰湿型多囊卵巢综合征不孕症患者效果观察[J]. 青岛医药卫生, 2021, 53(6): 420-423.
|